First cohort of the Sovereign AI Fund supporting UK-based AI companies building in priority sectors.

Funding for UK businesses developing AI solutions that demonstrably improve economic productivity.

This UKRI funding opportunity, previously known as the 'Developmental pathway funding scheme: stage one,' supports the development and testing of novel therapeutics, medical devices, diagnostics, and other interventions. It is open to researchers employed at eligible research organizations. The funding aims to advance early-stage medical innovations towards practical application.

This UKRI funding opportunity aims to establish a UK Obesity Research Institute focused on world-leading research into the biomedical drivers of obesity. It seeks to develop targeted interventions for prevention and treatment. The funding is for UK-based research organisations eligible for MRC funding, though specific amounts and application deadlines are not yet detailed.